CELH
Overvalued by 103.5% based on the discounted cash flow analysis.
Market cap | $21.58 Billion |
---|---|
Enterprise Value | $20.70 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.91 |
Beta | 1.46 |
Outstanding Shares | 233,081,303 |
Avg 30 Day Volume | 4,921,897 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 100.2 |
---|---|
PEG | 94.73 |
Price to Sales | 15.5 |
Price to Book Ratio | 23.26 |
Enterprise Value to Revenue | 14.64 |
Enterprise Value to EBIT | 67.94 |
Enterprise Value to Net Income | 96 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...